Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/25787
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3504]
Metadata
Show full item record
OUTCOMES OF HIV-POSITIVE PATIENTS WITH CRYPTOCOCCAL MENINGITIS IN THE AMERICAS
Author
Affilliation
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz.Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidad de Chile, Fundación Arriarán, Santiago, Chile
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz.Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidad de Chile, Fundación Arriarán, Santiago, Chile
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Abstract
Cryptococcal meningitis (CM) is associated with substantial mortality in HIV-infected patients. Optimal timing of antiretroviral therapy (ART) in persons with CM represents a clinical challenge, and the burden of CM in Latin America has not been well described. Studies suggest that early ART initiation is associated with higher mortality, but data from the Americas are scarce.
Share